V

Vor Biopharma
D

VOR

15.170
USD
-0.57
(-3.62%)
مغلق
حجم التداول
44,078
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
741,505,111
المقالات
المزيد

العنوان: Vor Biopharma Inc

القطاع: Healthcare
الصناعة: Biotechnology
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.